ea0049ep537 | Diabetes complications | ECE2017
Pofi Riccardo
, Fiore Daniela
, Feola Tiziana
, Giannetta Elisa
, Grazie Giulia Le
, Dato Carla Di
, Gianfrilli Daniele
, Barbano Biagio
, Venneri Mary A.
, Lenzi Andrea
, Isidori Andrea M.
One third of diabetic patients suffer from Diabetic Nephropathy (DN) that leads to end-stage renal disease (ESRD). The molecular pathways involved remain underexplored. We showed that chronic phosphodiesterase-5 inhibition (PDE5i) improve vascular inflammation [1] and tissue remodelling, reducing proteinuria [2] in murine diabetes. Our aim was to investigate the effect of PDE5i on animal and human models of DN.Materials and methods: 16 mice were randomly...